Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Esperion Therapeutics, Inc.”

53 pharma patents match "Esperion Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 53
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 53 pharmaceutical patents matching "Esperion Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

53 results for “Esperion Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 6459003

    Ether compounds

    Esperion Therapeutics, Inc. · Granted Oct 1, 2002 · Expires Sep 26, 2022

    expired

  2. US 6410802

    Methods for synthesizing ether compounds and intermediates therefor

    Esperion Therapeutics, Inc. · Granted Jun 25, 2002 · Expires Jun 20, 2022

    expired

  3. US 6376464

    Lipid complexes of APO A-1 agonist compounds

    Esperion Therapeutics, Inc. · Granted Apr 23, 2002 · Expires Apr 18, 2022

    expired

  4. US 6329341

    Method of treating septic shock

    Esperion Therapeutics, Inc. · Granted Dec 11, 2001 · Expires Dec 6, 2021

    expired

  5. US 6287590

    Peptide/lipid complex formation by co-lyophilization

    Esperion Therapeutics, Inc. · Granted Sep 11, 2001 · Expires Sep 6, 2021

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.